| Neoantigen-directed immune escape in lung cancer evolution R Rosenthal, EL Cadieux, R Salgado, MA Bakir, DA Moore, CT Hiley, ... Nature 567 (7749), 479-485, 2019 | 724 | 2019 |
| Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity A Serrels, T Lund, B Serrels, A Byron, RC McPherson, A von Kriegsheim, ... Cell 163 (1), 160-173, 2015 | 381 | 2015 |
| Geospatial immune variability illuminates differential evolution of lung adenocarcinoma K AbdulJabbar, SEA Raza, R Rosenthal, M Jamal-Hanjani, S Veeriah, ... Nature medicine 26 (7), 1054-1062, 2020 | 226 | 2020 |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ... Cancer cell 39 (11), 1497-1518. e11, 2021 | 151 | 2021 |
| The T cell differentiation landscape is shaped by tumour mutations in lung cancer E Ghorani, JL Reading, JY Henry, MR Massy, R Rosenthal, V Turati, ... Nature cancer 1 (5), 546-561, 2020 | 86 | 2020 |
| Immune surveillance in clinical regression of preinvasive squamous cell lung cancer A Pennycuick, VH Teixeira, K AbdulJabbar, SEA Raza, T Lund, ... Cancer discovery 10 (10), 1489-1499, 2020 | 72 | 2020 |
| TRACERx consortium. Neoantigen-directed immune escape in lung cancer evolution R Rosenthal, EL Cadieux, R Salgado, MA Bakir, DA Moore, CT Hiley, ... Nature 567 (7749), 479-85, 2019 | 48 | 2019 |
| Sherene Loi, Allan Hackshaw, Teresa Marafioti, Sergio A Quezada, Nicholas McGranahan, John Le Quesne, TRACERx Consortium, Charles Swanton, and Yinyin Yuan. Geospatial immune … K AbdulJabbar, SEA Raza, R Rosenthal, M Jamal-Hanjani, S Veeriah, ... Nat. Med., May, 2020 | 2 | 2020 |
| Genetic and immune landscape evolution in MMR‐deficient colorectal cancer BR Challoner, A Woolston, D Lau, M Buzzetti, C Fong, LJ Barber, ... The Journal of Pathology 262 (2), 226-239, 2024 | 1 | 2024 |
| An AI based Digital Score of Tumour-Immune Microenvironment Predicts Benefit to Maintenance Immunotherapy in Advanced Oesophagogastric Adenocarcinoma QD Vu, C Fong, A Gordon, T Lund, TL Silveira, D Rodrigues, K von Loga, ... arXiv preprint arXiv:2402.19296, 2024 | | 2024 |
| Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer BR Challoner, A Woolston, D Lau, M Buzzetti, C Fong, LJ Barber, ... bioRxiv, 2022.02. 16.479224, 2022 | | 2022 |
| P03. 30 Tumur mutations drive dysfunctional T cell differentiation in lung cancer E Ghorani, J Reading, J Henry, MR de Massy, R Rosenthal, V Turati, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 2), 2020 | | 2020 |
| Abstract A189: FAK inhibition induces T cell-mediated tumor regression: A novel role for nuclear FAK in controlling Tregs via transcription of cytokine networks A Serrels, T Lund, B Serrels, A Bryon, J Ring, JA Pachter, VG Brunton, ... Molecular Cancer Therapeutics 14 (12_Supplement_2), A189-A189, 2015 | | 2015 |
